AppSAA mice recapitulate age-dependent, human-relevant AD phenotypes with defined therapeutic windows for preclinical research and is available without restriction from The Jackson Laboratory.
Overall, non-cognitive and working memory deficits emerge early, while spatial memory impairment and amyloid pathology dominate at later stages, in the hAPP-J20 mouse model.
Geoffrey Canet, C. Zussy, Léa Otaegui et al.· Behavioural Brain Research· 0 citations
The findings indicate that the APPswe/PS1dE9 mouse model does not exhibit evidence of major integrative brain clearance impairment, despite this being a hallmark of sporadic AD in humans and suggest limitations of this model for studying clearance-related mechanisms of late-onset AD should be acknowledged when planning...
L. Müller, Charlotte Köhler, T. Lindner et al.· Fluids and Barriers of the C...· 0 citations
Examination of microglial gene expression in the brains of AppNL-F knock-in mice reveals a stepwise mode of microglial gene activation under slow amyloid progression and identifies novel genes that may be relevant to the early stages of Alzheimer's disease.
K. Shirotani, Daisuke Hatta, Kaori Watanabe et al.· Biological and Pharmaceutica...· 0 citations
Data suggest an increase in neuronal excitability in P301L mice compared with WT, but that this phenotype is not correlated with the age-dependent accumulation of AT8-labeled tau aggregates and the accompanying neuroinflammation.
K. Dunton, Hugo Monchal, Brie E Achorn et al.· Frontiers in Neuroscience· 0 citations
AD leads to changes in chronic inflammasome expression and neurodegenerative pathology, with marked sex-dependent differences in inflammatory and signaling responses in AD with TBI, which underscores the importance of considering both AD comorbidity and biological sex in the evaluation of TBI outcomes and therapeutic s...
Erika D. L. R. M. Cabrera Ranaldi, Nathan H. Johnson, A. Sawaya et al.· Cells· 0 citations
It is shown that a disease-associated microglial subtype, characterized by elevated GPNMB expression and enriched for polygenic AD risk, expands with AD pathology and shows increased phagocytic activity, and MITF is identified as an upstream regulator required to maintain this microglial state.
Donghoon Lee, James M. Vicari, Christian Porras et al.· Nature Genetics· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.